Published in J Virol on July 01, 1993
Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. J Virol (1995) 2.27
Persistent infection of macaques with simian-human immunodeficiency viruses. J Virol (1995) 2.22
The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor? J Virol (1996) 2.21
The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu. Retrovirology (2009) 2.11
The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses. J Virol (1996) 2.10
Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus. J Virol (1995) 1.50
Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain. J Virol (1996) 1.46
The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. Microbiol Rev (1995) 1.34
Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tetratricopeptide repeat protein family. J Virol (1998) 1.32
Molecular biology and pathogenesis of animal lentivirus infections. Clin Microbiol Rev (1996) 1.26
Distinct functions and requirements for the Cys-His boxes of the human immunodeficiency virus type 1 nucleocapsid protein during RNA encapsidation and replication. J Virol (1997) 0.99
Putative alpha-helical structures in the human immunodeficiency virus type 1 Vpu protein and CD4 are involved in binding and degradation of the CD4 molecule. J Virol (1997) 0.95
Restriction of Retroviral Replication by Tetherin/BST-2. Mol Biol Int (2012) 0.80
Vpu Protein: The Viroporin Encoded by HIV-1. Viruses (2015) 0.78
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol (1986) 37.70
Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science (1984) 32.33
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (1985) 30.47
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (1985) 21.57
Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science (1984) 15.82
Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J Virol (1992) 12.89
Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature (1986) 10.62
Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. J Virol (1990) 6.54
A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science (1988) 6.30
The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J Virol (1990) 6.08
Functional role of human immunodeficiency virus type 1 vpu. Proc Natl Acad Sci U S A (1989) 5.72
Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J Virol (1990) 5.01
Identification of a protein encoded by the vpu gene of HIV-1. Nature (1988) 4.05
Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. J Virol (1989) 3.90
Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. J Virol (1990) 3.42
Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J Virol (1992) 3.06
A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc Natl Acad Sci U S A (1992) 3.01
Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160. J Virol (1989) 2.58
Envelope glycoprotein and CD4 independence of vpu-facilitated human immunodeficiency virus type 1 capsid export. J Virol (1992) 2.05
Human-immunodeficiency-virus-type-1-encoded Vpu protein is phosphorylated by casein kinase II. Eur J Biochem (1992) 1.70
The effect of vpu on HIV-1-induced syncytia formation. J Acquir Immune Defic Syndr (1993) 1.25
Analysis of HIV-1 envelope mutants and pseudotyping of replication-defective HIV-1 vectors by genetic complementation. AIDS Res Hum Retroviruses (1992) 1.10
The terminal nucleotides of retrovirus DNA are required for integration but not virus production. Nature (1984) 4.89
The retrovirus pol gene encodes a product required for DNA integration: identification of a retrovirus int locus. Proc Natl Acad Sci U S A (1984) 4.81
The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. J Virol (1996) 3.91
Circles with two tandem LTRs are precursors to integrated retrovirus DNA. Cell (1984) 3.45
A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc Natl Acad Sci U S A (1992) 3.01
Human immunodeficiency virus vectors for inducible expression of foreign genes. J Virol (1992) 2.70
Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles. J Virol (1993) 2.17
Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation. J Virol (1997) 2.15
Position dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivo. J Virol (1997) 1.98
Role of reticuloendotheliosis virus envelope glycoprotein in superinfection interference. J Virol (1989) 1.83
N myristoylation of the spleen necrosis virus matrix protein is required for correct association of the Gag polyprotein with intracellular membranes and for particle formation. J Virol (1990) 1.71
Oxidation of methane in the absence of oxygen in lake water samples. Appl Environ Microbiol (1979) 1.70
Retroviral DNA integration. Cell (1985) 1.63
Trimeric hantavirus nucleocapsid protein binds specifically to the viral RNA panhandle. J Virol (2004) 1.57
Ultrastructure of HIV-1 genomic RNA. Virology (1997) 1.49
Cell type-dependence for Vpu function. J Med Primatol (1994) 1.47
Spleen necrosis virus gag polyprotein is necessary for particle assembly and release but not for proteolytic processing. J Virol (1990) 1.42
Storage of cellular 5' mRNA caps in P bodies for viral cap-snatching. Proc Natl Acad Sci U S A (2008) 1.39
Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tetratricopeptide repeat protein family. J Virol (1998) 1.32
The hantavirus nucleocapsid protein recognizes specific features of the viral RNA panhandle and is altered in conformation upon RNA binding. J Virol (2005) 1.30
Replication of the retroviral terminal repeat sequence during in vivo reverse transcription. J Virol (1993) 1.29
Hantavirus N protein exhibits genus-specific recognition of the viral RNA panhandle. J Virol (2006) 1.28
Spleen necrosis virus, an avian immunosuppressive retrovirus, shares a receptor with the type D simian retroviruses. J Virol (1992) 1.24
Human immunodeficiency virus type 1 RNA outside the primary encapsidation and dimer linkage region affects RNA dimer stability in vivo. J Virol (1997) 1.23
Duplication of the primary encapsidation and dimer linkage region of human immunodeficiency virus type 1 RNA results in the appearance of monomeric RNA in virions. J Virol (2001) 1.16
Bacillus subtilis RNAase III cleavage sites in phage SP82 early mRNA. Cell (1983) 1.13
HIV-1 particle release mediated by Vpu is distinct from that mediated by p6. Virology (1996) 1.12
Characterization of the RNA chaperone activity of hantavirus nucleocapsid protein. J Virol (2006) 1.10
Analysis of HIV-1 envelope mutants and pseudotyping of replication-defective HIV-1 vectors by genetic complementation. AIDS Res Hum Retroviruses (1992) 1.10
Purification and properties of a new bacillus subtilis RNA processing enzyme. Cleavage of phage SP82 mRNA and Bacillus subtilis precursor rRNA. J Biol Chem (1983) 1.03
Pleiotropic mutations in the HIV-1 matrix protein that affect diverse steps in replication. Virology (1997) 1.00
Distinct functions and requirements for the Cys-His boxes of the human immunodeficiency virus type 1 nucleocapsid protein during RNA encapsidation and replication. J Virol (1997) 0.99
Studies on the role of the V3 loop in human immunodeficiency virus type 1 envelope glycoprotein function. AIDS Res Hum Retroviruses (1992) 0.95
Association of Vpu-binding protein with microtubules and Vpu-dependent redistribution of HIV-1 Gag protein. Virology (2001) 0.95
The spleen necrosis virus int gene product expressed in Escherichia coli has DNA binding activity and mediates att and U5-specific DNA multimer formation in vitro. Virology (1987) 0.91
The HIV-1 matrix domain of Gag is required for Vpu responsiveness during particle release. Virology (1997) 0.90
Effects of second-site mutations on dominant interference by a human immunodeficiency virus type 1 envelope glycoprotein mutant. J Virol (1995) 0.89
Cells induced to express a human immunodeficiency virus type 1 envelope gene mutant inhibit the spread of wild-type virus. Hum Gene Ther (1992) 0.87
The full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression. J Virol (1993) 0.85
Analysis of bacteriophage SP82 major "early" in vitro transcripts. J Virol (1981) 0.85
Optimization of PCR for quantification of simian immunodeficiency virus genomic RNA in plasma of rhesus macaques (Macaca mulatta) using armored RNA. J Med Primatol (2013) 0.84
Propagation of SIV vectors by genetic complementation with a heterologous env gene. AIDS Res Hum Retroviruses (1992) 0.84
Simian immunodeficiency virus vectors: replication and pseudotyping. J Med Primatol (1992) 0.83
The matrix region is responsible for the differential ability of two retroviruses to function as helpers for vector propagation. Virology (1993) 0.83
N-linked glycosylation and reticuloendotheliosis retrovirus envelope glycoprotein function. Virology (1990) 0.78
Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tetratricopeptide repeat protein family. J Virol (1998) 0.78
Insertion of genes into retrovirus genomes and of retrovirus DNA into cell genomes. Prog Med Virol (1985) 0.76
Examination of TAR-independent Trans activation by human immunodeficiency virus type 1 Tat in human glial cells. J Neurosci Res (1996) 0.76